Get Premium to unlock powerful stock data

Foresite Capital Management V, LLC Buys Pardes Biosciences Inc, Theseus Pharmaceuticals Inc, Compass Therapeutics Inc, Sells Cullinan Oncology Inc, Nurix Therapeutics Inc, FS Development Corp II

Author's Avatar
Feb 19, 2022
Article's Main Image
Investment company Foresite Capital Management V, LLC (Current Portfolio) buys Pardes Biosciences Inc, Theseus Pharmaceuticals Inc, Compass Therapeutics Inc, Adicet Bio Inc, Hims & Hers Health Inc, sells Cullinan Oncology Inc, Nurix Therapeutics Inc, FS Development Corp II, Pharvaris NV, Population Health Investment Co Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Foresite Capital Management V, LLC. As of 2021Q4, Foresite Capital Management V, LLC owns 16 stocks with a total value of $407 million. These are the details of the buys and sells.

For the details of Foresite Capital Management V, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/foresite+capital+management+v%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Foresite Capital Management V, LLC
  1. Pardes Biosciences Inc (PRDS) - 9,400,515 shares, 37.81% of the total portfolio. New Position
  2. SomaLogic Inc (SLGC) - 5,326,472 shares, 15.23% of the total portfolio.
  3. Theseus Pharmaceuticals Inc (THRX) - 3,212,732 shares, 10.01% of the total portfolio. New Position
  4. Quantum-Si Inc (QSI) - 2,342,061 shares, 4.53% of the total portfolio.
  5. Aclaris Therapeutics Inc (ACRS) - 1,258,243 shares, 4.49% of the total portfolio.
New Purchase: Pardes Biosciences Inc (PRDS)

Foresite Capital Management V, LLC initiated holding in Pardes Biosciences Inc. The purchase prices were between $10.62 and $17.02, with an estimated average price of $13.8. The stock is now traded at around $9.480000. The impact to a portfolio due to this purchase was 37.81%. The holding were 9,400,515 shares as of 2021-12-31.

New Purchase: Theseus Pharmaceuticals Inc (THRX)

Foresite Capital Management V, LLC initiated holding in Theseus Pharmaceuticals Inc. The purchase prices were between $8.98 and $20.09, with an estimated average price of $15.08. The stock is now traded at around $11.210000. The impact to a portfolio due to this purchase was 10.01%. The holding were 3,212,732 shares as of 2021-12-31.

New Purchase: Compass Therapeutics Inc (CMPX)

Foresite Capital Management V, LLC initiated holding in Compass Therapeutics Inc. The purchase prices were between $2.88 and $4.08, with an estimated average price of $3.56. The stock is now traded at around $2.400000. The impact to a portfolio due to this purchase was 3.43%. The holding were 4,400,000 shares as of 2021-12-31.

New Purchase: Adicet Bio Inc (ACET)

Foresite Capital Management V, LLC initiated holding in Adicet Bio Inc. The purchase prices were between $7.37 and $17.49, with an estimated average price of $10.83. The stock is now traded at around $13.620000. The impact to a portfolio due to this purchase was 2.92%. The holding were 680,000 shares as of 2021-12-31.

Added: Hims & Hers Health Inc (HIMS)

Foresite Capital Management V, LLC added to a holding in Hims & Hers Health Inc by 61.50%. The purchase prices were between $5.5 and $8.46, with an estimated average price of $7.22. The stock is now traded at around $4.400000. The impact to a portfolio due to this purchase was 1.05%. The holding were 1,706,922 shares as of 2021-12-31.

Added: Adagio Therapeutics Inc (ADGI)

Foresite Capital Management V, LLC added to a holding in Adagio Therapeutics Inc by 36.26%. The purchase prices were between $6.35 and $47.04, with an estimated average price of $25.59. The stock is now traded at around $6.420000. The impact to a portfolio due to this purchase was 0.83%. The holding were 1,745,060 shares as of 2021-12-31.

Sold Out: Nurix Therapeutics Inc (NRIX)

Foresite Capital Management V, LLC sold out a holding in Nurix Therapeutics Inc. The sale prices were between $26.43 and $34.5, with an estimated average price of $30.31.

Sold Out: FS Development Corp II (FSII)

Foresite Capital Management V, LLC sold out a holding in FS Development Corp II. The sale prices were between $9.8 and $14.97, with an estimated average price of $11.43.

Sold Out: Population Health Investment Co Inc (PHICU)

Foresite Capital Management V, LLC sold out a holding in Population Health Investment Co Inc. The sale prices were between $9.92 and $10.51, with an estimated average price of $10.04.

Sold Out: Helix Acquisition Corp (HLXA)

Foresite Capital Management V, LLC sold out a holding in Helix Acquisition Corp. The sale prices were between $9.86 and $10.15, with an estimated average price of $9.93.

Sold Out: Lucira Health Inc (LHDX)

Foresite Capital Management V, LLC sold out a holding in Lucira Health Inc. The sale prices were between $4.94 and $8.94, with an estimated average price of $6.38.



Here is the complete portfolio of Foresite Capital Management V, LLC. Also check out:

1. Foresite Capital Management V, LLC's Undervalued Stocks
2. Foresite Capital Management V, LLC's Top Growth Companies, and
3. Foresite Capital Management V, LLC's High Yield stocks
4. Stocks that Foresite Capital Management V, LLC keeps buying
Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles